Compile Data Set for Download or QSAR
Report error Found 54 Enz. Inhib. hit(s) with all data for entry = 9690
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481873(US10913744, Compound 12)
Affinity DataIC50: 1.10nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481880(US10913744, Compound 19)
Affinity DataIC50: 1.40nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481874(US10913744, Compound 13)
Affinity DataIC50: 1.60nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481877(US10913744, Compound 16)
Affinity DataIC50: 2.10nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481879(US10913744, Compound 18 | (4-((5-chloro-4-(methyla...)
Affinity DataIC50: 2.20nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481879(US10913744, Compound 18 | (4-((5-chloro-4-(methyla...)
Affinity DataIC50: 2.20nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481874(US10913744, Compound 13)
Affinity DataIC50: 2.40nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481876(US10913744, Compound 15)
Affinity DataIC50: 2.40nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481873(US10913744, Compound 12)
Affinity DataIC50: 2.5nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481869(US10913744, Compound 8 | BDBM481884)
Affinity DataIC50: 2.60nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481872(US10913744, Compound 11)
Affinity DataIC50: 3nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481883(US10913744, Compound 22)
Affinity DataIC50: 3nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481883(US10913744, Compound 22)
Affinity DataIC50: 3nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM482160(HG-10-102-01 | BDBM50396041)
Affinity DataIC50: 3.20nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481875(US10913744, Compound 14)
Affinity DataIC50: 3.30nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481872(US10913744, Compound 11)
Affinity DataIC50: 4nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481869(US10913744, Compound 8 | BDBM481884)
Affinity DataIC50: 4nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481875(US10913744, Compound 14)
Affinity DataIC50: 4.40nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481880(US10913744, Compound 19)
Affinity DataIC50: 4.40nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481876(US10913744, Compound 15)
Affinity DataIC50: 4.70nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481869(US10913744, Compound 8 | BDBM481884)
Affinity DataIC50: 5.10nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM482157(LRRK2-IN-1 | BDBM50379529 | US11370796, Compound L...)
Affinity DataIC50: 6nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM482158(TAE684 | BDBM50242742)
Affinity DataIC50: 6.10nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481879(US10913744, Compound 18 | (4-((5-chloro-4-(methyla...)
Affinity DataIC50: 6.5nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481879(US10913744, Compound 18 | (4-((5-chloro-4-(methyla...)
Affinity DataIC50: 6.60nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481877(US10913744, Compound 16)
Affinity DataIC50: 7.10nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481881(US10913744, Compound 20)
Affinity DataIC50: 7.70nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM482158(TAE684 | BDBM50242742)
Affinity DataIC50: 7.80nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM482159(GSK2578215A | BDBM50401284)
Affinity DataIC50: 8.90nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM482159(GSK2578215A | BDBM50401284)
Affinity DataIC50: 10.9nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481869(US10913744, Compound 8 | BDBM481884)
Affinity DataIC50: 11.5nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481881(US10913744, Compound 20)
Affinity DataIC50: 12.4nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM482157(LRRK2-IN-1 | BDBM50379529 | US11370796, Compound L...)
Affinity DataIC50: 13nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481870((3-methoxy-4-((4-methoxy-7H-pyrrolo[2,3-d]pyrimidi...)
Affinity DataIC50: 13.6nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481885(US10913744, Compound 24)
Affinity DataIC50: 18.5nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481885(US10913744, Compound 24)
Affinity DataIC50: 19.4nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

LigandPNGBDBM481879(US10913744, Compound 18 | (4-((5-chloro-4-(methyla...)
Affinity DataIC50: 19.8nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM482160(HG-10-102-01 | BDBM50396041)
Affinity DataIC50: 20.3nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

LigandPNGBDBM482158(TAE684 | BDBM50242742)
Affinity DataIC50: 21.9nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481871(US10913744, Compound 10)
Affinity DataIC50: 34nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481882(US10913744, Compound 21)
Affinity DataIC50: 35nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481871(US10913744, Compound 10)
Affinity DataIC50: 40nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481882(US10913744, Compound 21)
Affinity DataIC50: 44nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,A2016T](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481879(US10913744, Compound 18 | (4-((5-chloro-4-(methyla...)
Affinity DataIC50: 47.7nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

LigandPNGBDBM482159(GSK2578215A | BDBM50401284)
Affinity DataIC50: 61.3nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,A2016T](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM482159(GSK2578215A | BDBM50401284)
Affinity DataIC50: 81.1nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,A2016T](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM482158(TAE684 | BDBM50242742)
Affinity DataIC50: 93.3nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481870((3-methoxy-4-((4-methoxy-7H-pyrrolo[2,3-d]pyrimidi...)
Affinity DataIC50: 95.7nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

LigandPNGBDBM482160(HG-10-102-01 | BDBM50396041)
Affinity DataIC50: 95.9nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [1326-2527,G2019S](Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM481878(US10913744, Compound 17)
Affinity DataIC50: 108nMAssay Description:Active GST-LRRK2 (1326-2527), GST-LRRK2[G2019S] (1326-2527), GST-LRRK2[A2016T] (1326-2527) and GST-LRRK2[A2016T+G2019S] (1326-2527) enzyme was purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

Displayed 1 to 50 (of 54 total ) | Next | Last >>
Jump to: